Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 15/20 | 0.64 |
| ▸ | NOX1 | Q9Y5S8 | 2/20 | 0.45 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.45 |
| ▸ | SNCA | P37840 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19918106 | 0.91 | SNCA (0.60) | BCHENOX1NR1H2SNCAMEN1 | |
| SCHEMBL29406451 | 0.91 | SNCA (0.60) | BCHENOX1NR1H2SNCAMEN1 | |
| SCHEMBL31022783 | 0.82 | BCHE (0.64) | BCHENOX1MEN1KMT2AMAPT | |
| SCHEMBL12813131 | 0.82 | BCHE (0.64) | BCHENOX1MEN1KMT2AMAPT | |
| SCHEMBL10083549 | 0.80 | BCHE (0.61) | BCHESNCAMEN1KMT2AL3MBTL1 | |
| SCHEMBL14142982 | 0.80 | BCHE (0.61) | BCHENOX1SNCA | |
| SCHEMBL29850660 | 0.78 | NOX1 (0.58) | BCHENOX1SNCAMEN1KMT2A | |
| SCHEMBL1208165 | 0.78 | NOX1 (0.58) | BCHENOX1SNCAMEN1KMT2A | |
| Ammonia Solution, Strong SCHEMBL1927787 | 0.76 | NOX1 (0.56) | BCHENOX1SNCAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL1929442 | 0.76 | NOX1 (0.56) | BCHENOX1SNCAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8809317-B2 | Antiviral compounds | PROSETTA ANTIVIRAL INC. (US) | 2014-08-19 | — | — | US | disclosed |
| US-20120302556-A1 | Antiviral Compounds | PROSETTA ANTIVIRAL INC. (US) | 2012-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120302556-A1 | Antiviral Compounds | HAVCR2, MAVS, EIF2AK2 | BCHE 857/4885NOX1 2733/4885NR1H2 1330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.